Open access
Open access
Powered by Google Translator Translator

RCT | Subcutaneous vs. transvenous implantable cardioverter defibrillator implantations.

22 Nov, 2022 | 13:19h | UTC

Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations: A Randomized, Multicenter Trial – Annals of Internal Medicine (link to abstract – $ for full-text) 

News Release: S-ICD Associated with 92 Percent Reduction in Lead-Related Complications Typical in Patients with ICDs – American College of Physicians 


Subcutaneous ICD Reduces Lead-Related Complications – HealthDay 

Subcutaneous implantable cardioverter defibrillators reduce the risk of perioperative complications – Physician’s Weekly 


Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial – European Heart Journal 

Subcutaneous or Transvenous Defibrillator Therapy – New England Journal of Medicine 


Commentary on Twitter 



Stay Updated in Your Specialty

No spam, just news.